<VariationArchive RecordType="classified" VariationID="39579" VariationName="NM_003647.3(DGKE):c.610del (p.Thr204fs)" VariationType="Deletion" Accession="VCV000039579" Version="4" NumberOfSubmissions="4" NumberOfSubmitters="4" DateLastUpdated="2023-01-07" DateCreated="2015-07-25" MostRecentSubmission="2022-12-31">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="48178" VariationID="39579">
      <GeneList>
        <Gene Symbol="DGKE" FullName="diacylglycerol kinase epsilon" GeneID="8526" HGNC_ID="HGNC:2852" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>17q22</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="56834151" stop="56869567" display_start="56834151" display_stop="56869567" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="54911459" stop="54946035" display_start="54911459" display_stop="54946035" Strand="+" />
          </Location>
          <OMIM>601440</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_003647.3(DGKE):c.610del (p.Thr204fs)</Name>
      <CanonicalSPDI>NC_000017.11:56844157:AAAAAAA:AAAAAA</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>17q22</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="56844158" stop="56844158" display_start="56844158" display_stop="56844158" variantLength="1" positionVCF="56844157" referenceAlleleVCF="CA" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="54921519" stop="54921519" display_start="54921519" display_stop="54921519" variantLength="1" positionVCF="54921518" referenceAlleleVCF="CA" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>T204fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.10" sequenceAccession="NC_000017" sequenceVersion="10" change="g.54921525del" Assembly="GRCh37">
            <Expression>NC_000017.10:g.54921525del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.11" sequenceAccession="NC_000017" sequenceVersion="11" change="g.56844164del" Assembly="GRCh38">
            <Expression>NC_000017.11:g.56844164del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_033888.1" sequenceAccession="NG_033888" sequenceVersion="1" change="g.15066del">
            <Expression>NG_033888.1:g.15066del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003647.3" sequenceAccession="NM_003647" sequenceVersion="3" change="c.610del" MANESelect="true">
            <Expression>NM_003647.3:c.610del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_003638.1" sequenceAccession="NP_003638" sequenceVersion="1" change="p.Thr204fs">
            <Expression>NP_003638.1:p.Thr204fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003647.2" sequenceAccession="NM_003647" sequenceVersion="2" change="c.610delA">
            <Expression>NM_003647.2:c.610delA</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA10575566" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="601440.0002" DB="OMIM" />
        <XRef Type="rs" ID="147972030" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_003647.3(DGKE):c.610del (p.Thr204fs) AND Immunoglobulin-mediated membranoproliferative glomerulonephritis" Accession="RCV000032779" Version="6">
        <ClassifiedConditionList TraitSetID="9121">
          <ClassifiedCondition DB="MedGen" ID="C3554330">Immunoglobulin-mediated membranoproliferative glomerulonephritis</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2022-02-26" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_003647.3(DGKE):c.610del (p.Thr204fs) AND Nephrotic syndrome" Accession="RCV001849287" Version="1">
        <ClassifiedConditionList TraitSetID="16911">
          <ClassifiedCondition DB="MedGen" ID="C0027726">Nephrotic syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2017-11-10" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-02-26" NumberOfSubmissions="4" NumberOfSubmitters="4" DateCreated="2015-07-25" MostRecentSubmission="2022-12-31">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">23274426</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25349199</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">29127259</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="16911" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="21310" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Nephrotic syndrome</ElementValue>
                <XRef ID="HP:0000100" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0005377" DB="MONDO" />
                <XRef ID="52254009" DB="SNOMED CT" />
              </Name>
              <XRef ID="C0027726" DB="MedGen" />
              <XRef ID="MONDO:0005377" DB="MONDO" />
              <XRef Type="primary" ID="HP:0000100" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0000801" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0004718" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0008638" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0008727" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9121" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17531" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">NEPHROTIC SYNDROME, TYPE 7, WITH MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS</ElementValue>
                <XRef Type="MIM" ID="615008" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Nephrotic syndrome, type 7</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Immunoglobulin-mediated membranoproliferative glomerulonephritis</ElementValue>
                <XRef ID="MONDO:0014005" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">NPHS7</ElementValue>
                <XRef Type="MIM" ID="615008" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">C3 glomerulopathy (C3G) is a complex ultra-rare complement-mediated renal disease caused by uncontrolled activation of the complement alternative pathway (AP) in the fluid phase (as opposed to cell surface) that is rarely inherited in a simple mendelian fashion. C3G affects individuals of all ages, with a median age at diagnosis of 23 years. Individuals with C3G typically present with hematuria, proteinuria, hematuria and proteinuria, acute nephritic syndrome or nephrotic syndrome, and low levels of the complement component C3. Spontaneous remission of C3G is uncommon, and about half of affected individuals develop end-stage renal disease (ESRD) within ten years of diagnosis, occasionally developing the late comorbidity of impaired visual acuity.</Attribute>
                <XRef ID="NBK1425" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301598</ID>
                <ID Source="BookShelf">NBK1425</ID>
              </Citation>
              <XRef ID="329903" DB="Orphanet" />
              <XRef ID="C3554330" DB="MedGen" />
              <XRef ID="MONDO:0014005" DB="MONDO" />
              <XRef Type="MIM" ID="615008" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="93739" SubmissionDate="2015-07-23" DateLastUpdated="2015-07-25" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="601440.0002_NEPHROTIC SYNDROME, TYPE 7" title="DGKE, 1-BP DEL, 610A_NEPHROTIC SYNDROME, TYPE 7" />
        <ClinVarAccession Accession="SCV000056543" DateUpdated="2015-07-25" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2013-02-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 2 sibs, born of consanguineous Turkish parents, with nephrotic syndrome type 7 (NPHS7; 615008), Ozaltin et al. (2013) identified a 1-bp deletion (610delA) in exon 2 of the DGKE gene, resulting in a frameshift and premature termination (Thr204GlnfsTer6). The unaffected parents was heterozygous for the mutation. A heterozygous 610delA allele was found in 1 individual in the 1000 Genomes Project, but was not present in 6,503 samples of another exome database, yielding an allele frequency of 0.0002.</Attribute>
              <Citation>
                <ID Source="PubMed">23274426</ID>
              </Citation>
              <XRef DB="OMIM" ID="615008" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="DGKE" />
          </GeneList>
          <Name>DGKE, 1-BP DEL, 610A</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 610A</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="601440.0002" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">NEPHROTIC SYNDROME, TYPE 7</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2892666" SubmissionDate="2020-12-31" DateLastUpdated="2021-01-07" DateCreated="2021-01-07">
        <ClinVarSubmissionID localKey="NM_003647.2:c.610delA|MedGen:C3554330" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001467967" DateUpdated="2021-01-07" DateCreated="2021-01-07" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-12-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">25349199</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23274426</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">29127259</ID>
          </Citation>
          <Comment>Variant summary: DGKE c.610delA (p.Thr204GlnfsX6) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant allele was found at a frequency of 2.7e-05 in 186148 control chromosomes (gnomAD). c.610delA has been reported in the literature in two homozygous siblings from a Turkish consanguineous family affected with membranoproliferative-like glomerularmicroangiopathy (Ozaltin_2013). These data indicate that the variant is likely to be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function (Ozaltin_2013). No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="DGKE" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_003647.2:c.610delA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Nephrotic syndrome, type 7</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C3554330" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8831147</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4124020" SubmissionDate="2022-03-21" DateLastUpdated="2022-03-28" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="NM_003647.3:c.610del|HPO:0000100" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002106647" DateUpdated="2022-03-28" DateCreated="2022-03-28" Type="SCV" Version="1" SubmitterName="Yale Center for Mendelian Genomics, Yale University" OrgID="506150" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-11-10">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">29127259</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Homozygote" integerValue="2" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_003647.3:c.610del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="HP" ID="HP:0000100" />
          </Trait>
        </TraitSet>
        <StudyName>Yale Center for Mendelian Genomics</StudyName>
        <StudyDescription>The Yale Center for Mendelian Genomics is one of the national centers created by the NIH to study the genetics of rare inherited diseases.</StudyDescription>
        <SubmissionNameList>
          <SubmissionName>SUB11200512</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5436140" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_003647.3:c.610del|OMIM:615008" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002778278" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="clinic" OrgAbbreviation="FLGT" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-02-26">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_003647.3:c.610del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="615008" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4124020" TraitType="Disease" MappingType="XRef" MappingValue="HP:0000100" MappingRef="HP">
        <MedGen CUI="C0027726" Name="Nephrotic syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="93739" TraitType="Disease" MappingType="Name" MappingValue="NEPHROTIC SYNDROME, TYPE 7" MappingRef="Preferred">
        <MedGen CUI="C3554330" Name="Immunoglobulin-mediated membranoproliferative glomerulonephritis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2892666" TraitType="Disease" MappingType="Name" MappingValue="Nephrotic syndrome, type 7" MappingRef="Preferred">
        <MedGen CUI="C3554330" Name="Immunoglobulin-mediated membranoproliferative glomerulonephritis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5436140" TraitType="Disease" MappingType="XRef" MappingValue="615008" MappingRef="OMIM">
        <MedGen CUI="C3554330" Name="Immunoglobulin-mediated membranoproliferative glomerulonephritis" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

